Company: SINT
Filing Date: 2025-10-03
Form Type: 424B5
Source: 0001493152-25-016902
Chunk: 11

Company: Sintx Technologies, Inc.
Filing Date: 2025-10-03
Form: 424B5
Chunk 11
---
 shares that will be sold or the gross proceeds to be raised in connection with those sales.

Sales of a significant number of shares of our common stock in the public markets, including pursuant to the Sales Agreement, or the perception that such sales could occur, could depress the market price of our common stock.

Sales of a substantial number of shares of our common stock in the public markets could depress the market price of our common stock and impair our ability to raise capital through the sale of additional equity securities. We cannot predict the size of future issuances or sales of shares of our Common Stock, including those made pursuant to the Sales Agreement with the sales agent or in connection with future acquisitions or capital raising activities, or the effect, if any, that such issuances or sales may have on the market price of our Common Stock. The issuance and sale of substantial amounts of shares of our Common Stock, including issuances and sales pursuant to the Sales Agreement, or announcement that such issuances and sales may occur, could adversely affect the market price of our Common Stock. If there are more shares of Common Stock offered for sale than buyers are willing to purchase, then the market price of our Common Stock may decline.

In addition, sales of stock by any of our executive officers or directors could have a material adverse effect on the trading price of our Common Stock.

You may experience future dilution as a result of future equity offerings.

In order to raise additional capital, we may at any time, including during the pendency of this offering, offer additional shares of our Common Stock or other securities convertible into or exchangeable for our Common Stock at prices that may not be the same as the price per share in this offering. We may sell shares or other securities in any other offering at a price per share that is less than the price per share paid by investors in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which we sell additional shares of our Common Stock, or securities convertible or exchangeable into our Common Stock, in future transactions may be higher or lower than the price per share paid by investors in this offering.

If you purchase shares of our Common Stock sold in this offering, you may incur immediate and substantial dilution.

Some or all of the public offering price per share in this offering may exceed the pro forma as-adjusted net tangible book value per share of our outstanding Common Stock. After giving effect to an assumed sale of shares of Common Stock in the aggregate amount of $6,